Bertil Lindmark
Chief Medical Officer, Damora Therapeutics, Inc.
Companies
- Damora Therapeutics, Inc.Chief Medical Officer Oct 28, 2020 to Jan 5, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Damora Therapeutics, Inc. DMRA16,604 shares2$304.2K at $18.32Mar 22, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 22, 2022Bought 14,604 shares at $2.16 of Damora Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2